Financials
- Market Capitalization 3.24 B
- Employee 354
- Founded 2016
- CEO Frank Watanabe
- Website www.arcutis.com
- Headquarter Delaware, United States
- FIGI BBG00QN8K4M4
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-223.38
Rapporto prezzo/fatturato
9.82
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 1581 | ACAD ACADIA Pharmaceuticals Inc. - Common Stock | 18.80 USD | -3.14% | -6.37% | -32.88% | -4.95% | 3.24 B USD | ||
| 1586 | VKTX Viking Therapeutics, Inc. - Common Stock | 27.84 USD | -1.76% | -4.03% | -12.18% | -15.28% | 3.25 B USD | ||
| 1592 | LEGN Legend Biotech Corporation - American Depositary Shares | 18.15 USD | +1.97% | -3.61% | -3.46% | -43.25% | 3.36 B USD | ||
| 1600 | TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 73.33 USD | -1.44% | -1.25% | -7.98% | +11.01% | 3.22 B USD |